Purchase Order 7571TE26P00327
- Not listed
- <p>CDC Pittsburgh awarded a purchase order to Clarivate Analytics (Us) LLC for MetaCore/MetaDrug licenses valued at $146,857.17 on April 10, 2023, with ultimate completion by April 10, 2028. The order is firm fixed price with no set-aside applied. Performance takes place in Chandler, Arizona. The purchase order was issued under a pre-solicitation opportunity posted March 17, 2023, with a proposal due date of March 28, 2023.</p>
- <p>CDC Pittsburgh awarded a purchase order to Clarivate Analytics (Us) LLC for MetaDrug software license on April 12, 2022, with a ceiling value of $42,599.91 and firm fixed price. Performance is located in Atlanta, Georgia, with an ultimate completion date of April 10, 2027. No set-aside was used. This procurement falls under Executive Order 14398.</p>
- This is a firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Clarivate Analytics (Us) LLC, a foreign-owned for-profit organization. The contract provides a software license and maintenance/support program for the METACORE platform. The potential value of the award is $120,355.61, and the period of performance runs through February 23, 2023. No set-aside designation was used for this...
- This is a $195,886.92 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Clarivate Analytics (Us) LLC, a foreign-owned for-profit organization, for an annual subscription to the Clarivate research database and analytics platforms. The contract has an ultimate completion date of September 12, 2028 and was awarded on September 13, 2023 without a set-aside designation. Clarivate Analytics provides scientific, technical, medical, and scholarly...
- CDC Pittsburgh, an agency component of the Department of Health and Human Services, awarded a purchase order to Clarivate Analytics (Us) LLC for a site license of EndNote software and associated technical support services valued at $190,264.26, with an award date of May 28, 2026. The order covers an enterprise-wide license with software upgrades, 24/7 technical support, live training, and installation rights across personal machines, iPad, and iPhone devices. Place of performance is Ann Arbor,...
- The Centers for Disease Control and Prevention (Pittsburgh) issued a purchase order to Merative US L.P. on August 18, 2023, for access to Redbook expanded monthly and historical price data files, with a ceiling value of $75,159.09 under firm fixed pricing. Performance of record is located in San Francisco, California, with an ultimate completion date of August 17, 2026. The procurement originated from a pre-solicitation posted June 16, 2023, with a closing date of June 26, 2023, and carries no...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order to Clarivate Analytics (Us) LLC, a foreign-owned for-profit organization, for a software subscription with a potential value of $201,477.04. The contract is for the provision of Clarivate's proprietary research databases, analytical tools, academic journals, and other scientific literature to support the agency's research, analysis, and program evaluation functions....
- <p>CDC Pittsburgh awarded a purchase order to Biomatters Incorporated for Geneious software with a ceiling value of $243,126.20 on February 23, 2021. No set-aside applied. Place of performance is San Diego, California. The order covers software subscriptions and licenses for Geneious Prime, a bioinformatics platform supporting molecular biology and genomic analysis research. Ultimate completion date is February 22, 2026.</p>
- The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a $284,847.50 firm fixed-price purchase order to Protein Metrics, LLC on September 1, 2023, with an ultimate completion date of August 31, 2028. This contract, which carries no set-aside designation, procures software licenses and protein analytics services from the vendor, a specialized provider of vendor-neutral software for mass spectrometry-based protein analysis. Protein Metrics' solutions enable advanced analytical...
- This is a federal contract award from the Centers for Disease Control and Prevention (CDC) to Clarivate Analytics (Us) LLC for software license renewal. The contract has a ceiling value of $125,592.00 and is a Firm Fixed Price Purchase Order. The award was made on January 1, 2017 with a completion date of January 19, 2020. The contract does not have a set-aside designation. Clarivate Analytics is a global provider of scientific, technical, and scholarly research tools, including proprietary...
CDC Pittsburgh, on behalf of the Centers for Disease Control and Prevention, issued a purchase order to Clarivate Analytics (US) LLC on September 2, 2026 for renewal of Clarivate MetaCore and MetaDrug software licenses, with a ceiling value of $22,319.36 and completion by August 31, 2027. This is a sole-source, firm-fixed-price procurement for proprietary bioinformatics software supporting the Simulation Science Section within the Office of Innovation and Analytics. The MetaCore/MetaDrug platform enables analysis of microarray, next-generation sequencing, metabolic, and other genomic data, with functional analysis, pathway and network mapping, and visualization capabilities. Performance is located in Boston, Massachusetts. The underlying contract opportunity, posted August 12, 2026, reflects a five-year period of performance running August 18, 2026 through August 17, 2031, structured in five annual periods. NAICS code 513210 (Software Publishers); PSC code 7A21 (IT and Telecom-Business Application Software, Perpetual License Software).
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
CDC Clarivate Meta Core Meta Drug | 75D301-26-Q-79153 | None | Solicitation 1/1 | 8/12/26, 11:42 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.3k | 9/1/26 |